7i1b › Citations

High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy.

Clore GM, Wingfield PT, Gronenborn AM
Biochemistry 30 2315-23 (1991)
Cited: 74 times
EuropePMC logo PMID: 2001363

Abstract

The determination of the high-resolution three-dimensional solution structure of interleukin 1 beta (IL-1 beta), a protein of 153 residues and 17.4 kDa, which plays a central role in the immune and inflammatory responses, has been determined by heteronuclear (13C and 15N) three- and four-dimensional NMR spectroscopy. The structure is based on 3146 experimental restraints comprising 2780 distance and 366 torsion angle (phi, psi, and chi 1) restraints. A total of 32 simulated annealing structures are calculated, and the atomic RMS distribution about the mean coordinate positions is 0.41 +/- 0.04 A for the backbone atoms and 0.82 +/- 0.04 A for all atoms (excluding residue 1 at the N-terminus and residues 152 and 153 at the C-terminus, which are partially disordered). In the case of internal side chains with a surface accessibility of less than or equal to 40%, the atomic RMS distribution about the mean coordinate positions for all atoms is 0.49 +/- 0.03 A. IL-1 beta resembles a tetrahedron and is composed of 12 beta-strands arranged in three pseudosymmetric topological units, each of which comprises 5 strands. Analysis of the mutational data on IL-1 beta in the light of the three-dimensional structure suggests the presence of three distinct binding sites for the IL-1 receptor on the surface of the protein. It is suggested that each of the three immunoglobulin domains which comprise the extracellular portion of the IL-1 receptor recognizes one of these sites.

Reviews citing this publication (17)

  1. Theory, practice, and applications of paramagnetic relaxation enhancement for the characterization of transient low-population states of biological macromolecules and their complexes. Clore GM, Iwahara J. Chem Rev 109 4108-4139 (2009)
  2. Mutations and off-pathway aggregation of proteins. Wetzel R. Trends Biotechnol 12 193-198 (1994)
  3. Computational challenges for macromolecular structure determination by X-ray crystallography and solution NMR-spectroscopy. Brünger AT, Nilges M. Q Rev Biophys 26 49-125 (1993)
  4. NMR structure determination of proteins and protein complexes larger than 20 kDa. Clore GM, Gronenborn AM. Curr Opin Chem Biol 2 564-570 (1998)
  5. Prospects for NMR of large proteins. Wagner G. J Biomol NMR 3 375-385 (1993)
  6. Functional implications of interleukin-1 beta based on the three-dimensional structure. Veerapandian B, Gilliland GL, Raag R, Svensson AL, Masui Y, Hirai Y, Poulos TL. Proteins 12 10-23 (1992)
  7. Comparison of protein structures determined by NMR in solution and by X-ray diffraction in single crystals. Billeter M. Q Rev Biophys 25 325-377 (1992)
  8. Young Investigator Award Lecture. Structures of larger proteins, protein-ligand and protein-DNA complexes by multidimensional heteronuclear NMR. Clore GM, Gronenborn AM. Protein Sci 3 372-390 (1994)
  9. Structures of protein complexes by multidimensional heteronuclear magnetic resonance spectroscopy. Gronenborn AM, Clore GM. Crit Rev Biochem Mol Biol 30 351-385 (1995)
  10. A review about nothing: are apolar cavities in proteins really empty? Matthews BW, Liu L. Protein Sci 18 494-502 (2009)
  11. Structures of larger proteins, protein-ligand and protein-DNA complexes by multi-dimensional heteronuclear NMR. Clore GM, Gronenborn AM. Prog Biophys Mol Biol 62 153-184 (1994)
  12. The blind watchmaker and rational protein engineering. Anthonsen HW, Baptista A, Drabløs F, Martel P, Petersen SB. J Biotechnol 36 185-220 (1994)
  13. Interferons alpha/beta and their receptors: place in the hierarchy of cytokines. Zav'Yalov VP, Zav'Yalova GA. APMIS 105 161-186 (1997)
  14. Preparation of Soluble Proteins from Escherichia coli. Wingfield PT. Curr Protoc Protein Sci 78 6.2.1-6.2.22 (2014)
  15. Three-dimensional structures of gonadotropins. Lustbader JW, Pollak S, Lobel L, Trakht I, Homans S, Brown JM, Canfield RE. Mol Cell Endocrinol 125 21-31 (1996)
  16. NMR structures and methodology. Chazin WJ. Curr Opin Biotechnol 3 326-332 (1992)
  17. Protein hormones and their receptors. Young PR. Curr Opin Biotechnol 3 408-421 (1992)

Articles citing this publication (57)

  1. beta-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 beta and 1 alpha and fibroblast growth factors. Murzin AG, Lesk AM, Chothia C. J Mol Biol 223 531-543 (1992)
  2. Hydrophilicity of cavities in proteins. Zhang L, Hermans J. Proteins 24 433-438 (1996)
  3. New methods of structure refinement for macromolecular structure determination by NMR. Clore GM, Gronenborn AM. Proc Natl Acad Sci U S A 95 5891-5898 (1998)
  4. The structure of a novel insecticidal neurotoxin, omega-atracotoxin-HV1, from the venom of an Australian funnel web spider. Fletcher JI, Smith R, O'Donoghue SI, Nilges M, Connor M, Howden ME, Christie MJ, King GF. Nat Struct Biol 4 559-566 (1997)
  5. Determination of a high-quality nuclear magnetic resonance solution structure of the bovine pancreatic trypsin inhibitor and comparison with three crystal structures. Berndt KD, Güntert P, Orbons LP, Wüthrich K. J Mol Biol 227 757-775 (1992)
  6. A 500 ps molecular dynamics simulation study of interleukin-1 beta in water. Correlation with nuclear magnetic resonance spectroscopy and crystallography. Chandrasekhar I, Clore GM, Szabo A, Gronenborn AM, Brooks BR. J Mol Biol 226 239-250 (1992)
  7. The structure of versutoxin (delta-atracotoxin-Hv1) provides insights into the binding of site 3 neurotoxins to the voltage-gated sodium channel. Fletcher JI, Chapman BE, Mackay JP, Howden ME, King GF. Structure 5 1525-1535 (1997)
  8. Engineering encodable lanthanide-binding tags into loop regions of proteins. Barthelmes K, Reynolds AM, Peisach E, Jonker HR, DeNunzio NJ, Allen KN, Imperiali B, Schwalbe H. J Am Chem Soc 133 808-819 (2011)
  9. Positive theta-angles in proteins by nuclear magnetic resonance spectroscopy. Ludvigsen S, Poulsen FM. J Biomol NMR 2 227-233 (1992)
  10. Multiple routes lead to the native state in the energy landscape of the beta-trefoil family. Chavez LL, Gosavi S, Jennings PA, Onuchic JN. Proc Natl Acad Sci U S A 103 10254-10258 (2006)
  11. Stereospecific assignment of beta-methylene protons in larger proteins using 3D 15N-separated Hartmann-Hahn and 13C-separated rotating frame Overhauser spectroscopy. Clore GM, Bax A, Gronenborn AM. J Biomol NMR 1 13-22 (1991)
  12. High-resolution structure of Ascaris trypsin inhibitor in solution: direct evidence for a pH-induced conformational transition in the reactive site. Grasberger BL, Clore GM, Gronenborn AM. Structure 2 669-678 (1994)
  13. Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline. Schreuder HA, Rondeau JM, Tardif C, Soffientini A, Sarubbi E, Akeson A, Bowlin TL, Yanofsky S, Barrett RW. Eur J Biochem 227 838-847 (1995)
  14. Structure of hisactophilin is similar to interleukin-1 beta and fibroblast growth factor. Habazettl J, Gondol D, Wiltscheck R, Otlewski J, Schleicher M, Holak TA. Nature 359 855-858 (1992)
  15. Protein phi and psi dihedral restraints determined from multidimensional hypersurface correlations of backbone chemical shifts and their use in the determination of protein tertiary structures. Beger RD, Bolton PH. J Biomol NMR 10 129-142 (1997)
  16. Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor. Labriola-Tompkins E, Chandran C, Kaffka KL, Biondi D, Graves BJ, Hatada M, Madison VS, Karas J, Kilian PL, Ju G. Proc Natl Acad Sci U S A 88 11182-11186 (1991)
  17. The solution structure of the N-terminal zinc finger of GATA-1 reveals a specific binding face for the transcriptional co-factor FOG. Kowalski K, Czolij R, King GF, Crossley M, Mackay JP. J Biomol NMR 13 249-262 (1999)
  18. Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution. Chang BS, Beauvais RM, Arakawa T, Narhi LO, Dong A, Aparisio DI, Carpenter JF. Biophys J 71 3399-3406 (1996)
  19. The solution structure of omega-Aga-IVB, a P-type calcium channel antagonist from venom of the funnel web spider, Agelenopsis aperta. Reily MD, Thanabal V, Adams ME. J Biomol NMR 5 122-132 (1995)
  20. Structural similarity of a developmentally regulated bacterial spore coat protein to beta gamma-crystallins of the vertebrate eye lens. Bagby S, Harvey TS, Eagle SG, Inouye S, Ikura M. Proc Natl Acad Sci U S A 91 4308-4312 (1994)
  21. Solution structure of calmodulin and its complex with a myosin light chain kinase fragment. Ikura M, Barbato G, Klee CB, Bax A. Cell Calcium 13 391-400 (1992)
  22. The native energy landscape for interleukin-1beta. Modulation of the population ensemble through native-state topology. Roy M, Chavez LL, Finke JM, Heidary DK, Onuchic JN, Jennings PA. J Mol Biol 348 335-347 (2005)
  23. Solution conformations of proline rings in proteins studied by NMR spectroscopy. Cai M, Huang Y, Liu J, Krishnamoorthi R. J Biomol NMR 6 123-128 (1995)
  24. Water in the polar and nonpolar cavities of the protein interleukin-1β. Yin H, Feng G, Clore GM, Hummer G, Rasaiah JC. J Phys Chem B 114 16290-16297 (2010)
  25. 1H, 15N, 13C and 13CO assignments and secondary structure determination of basic fibroblast growth factor using 3D heteronuclear NMR spectroscopy. Moy FJ, Seddon AP, Campbell EB, Böhlen P, Powers R. J Biomol NMR 6 245-254 (1995)
  26. Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity. Greenfeder SA, Varnell T, Powers G, Lombard-Gillooly K, Shuster D, McIntyre KW, Ryan DE, Levin W, Madison V, Ju G. J Biol Chem 270 22460-22466 (1995)
  27. Inclusion body formation by interleukin-1 beta depends on the thermal sensitivity of a folding intermediate. Wetzel R, Chrunyk BA. FEBS Lett 350 245-248 (1994)
  28. Localization of bound water in the solution structure of the immunoglobulin binding domain of streptococcal protein G. Evidence for solvent-induced helical distortion in solution. Clore GM, Gronenborn AM. J Mol Biol 223 853-856 (1992)
  29. Real-time NMR kinetic studies provide global and residue-specific information on the non-cooperative unfolding of the beta-trefoil protein, interleukin-1beta. Roy M, Jennings PA. J Mol Biol 328 693-703 (2003)
  30. A characteristic arrangement of aromatic amino acid residues in the solution structure of the amino-terminal RNA-binding domain of Drosophila sex-lethal. Inoue M, Muto Y, Sakamoto H, Kigawa T, Takio K, Shimura Y, Yokoyama S. J Mol Biol 272 82-94 (1997)
  31. Comparison of the solution nuclear magnetic resonance and X-ray crystal structures of human recombinant interleukin-1 beta. Clore GM, Gronenborn AM. J Mol Biol 221 47-53 (1991)
  32. Protein structure elucidation from NMR proton densities. Grishaev A, Llinas M. Proc Natl Acad Sci U S A 99 6713-6718 (2002)
  33. Determination of solvent content in cavities in IL-1beta using experimentally phased electron density. Quillin ML, Wingfield PT, Matthews BW. Proc Natl Acad Sci U S A 103 19749-19753 (2006)
  34. Determination of the positions of bound water molecules in the solution structure of reduced human thioredoxin by heteronuclear three-dimensional nuclear magnetic resonance spectroscopy. Forman-Kay JD, Gronenborn AM, Wingfield PT, Clore GM. J Mol Biol 220 209-216 (1991)
  35. Pro-interleukin (IL)-1beta shares a core region of stability as compared with mature IL-1beta while maintaining a distinctly different configurational landscape: a comparative hydrogen/deuterium exchange mass spectrometry study. Hailey KL, Li S, Andersen MD, Roy M, Woods VL, Jennings PA. J Biol Chem 284 26137-26148 (2009)
  36. Deletion mutants of human interleukin 1 beta with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors. Simoncsits A, Bristulf J, Tjörnhammar ML, Cserzö M, Pongor S, Rybakina E, Gatti S, Bartfai T. Cytokine 6 206-214 (1994)
  37. Three topologically equivalent core residues affect the transition state ensemble in a protein folding reaction. Heidary DK, Jennings PA. J Mol Biol 316 789-798 (2002)
  38. Long-range coupling between separate docking sites in interleukin-1beta. Heidary DK, Roy M, Daumy GO, Cong Y, Jennings PA. J Mol Biol 353 1187-1198 (2005)
  39. Biophysical characterization of structural properties and folding of interleukin-1 receptor antagonist. Latypov RF, Harvey TS, Liu D, Bondarenko PV, Kohno T, Fachini RA, Rosenfeld RD, Ketchem RR, Brems DN, Raibekas AA. J Mol Biol 368 1187-1201 (2007)
  40. Molecular cloning and characterization of beluga whale (Delphinapterus leucas) interleukin-1beta and tumor necrosis factor-alpha. Denis F, Archambault D. Can J Vet Res 65 233-240 (2001)
  41. Structure and function of interleukin-1, based on crystallographic and modeling studies. Veerapandian B. Biophys J 62 112-115 (1992)
  42. Understanding the folding-function tradeoff in proteins. Gosavi S. PLoS One 8 e61222 (2013)
  43. A reduced representation of proteins for use in restraint satisfaction calculations. Herzyk P, Hubbard RE. Proteins 17 310-324 (1993)
  44. Solution structure of human interleukin-1 receptor antagonist protein. Stockman BJ, Scahill TA, Strakalaitis NA, Brunner DP, Yem AW, Deibel MR. FEBS Lett 349 79-83 (1994)
  45. Bacterial production of biologically active canine interleukin-1beta by seamless SUMO tagging and removal. Kirkpatrick RB, Grooms M, Wang F, Fenderson H, Feild J, Pratta MA, Volker C, Scott G, Johanson K. Protein Expr Purif 50 102-110 (2006)
  46. Molecular dynamics free energy calculations to assess the possibility of water existence in protein nonpolar cavities. Oikawa M, Yonetani Y. Biophys J 98 2974-2983 (2010)
  47. Modeling the structure of Pyrococcus furiosus rubredoxin by homology to other X-ray structures. Wampler JE, Bradley EA, Stewart DE, Adams MW. Protein Sci 2 640-649 (1993)
  48. The solution structure of the leucine zipper motif of the Jun oncoprotein homodimer. Junius FK, Weiss AS, King GF. Eur J Biochem 214 415-424 (1993)
  49. Exhaustive enumeration of protein conformations using experimental restraints. DeWitte RS, Michnick SW, Shakhnovich EI. Protein Sci 4 1780-1791 (1995)
  50. Solution structure and dynamics of a serpin reactive site loop using interleukin 1beta as a presentation scaffold. Arico-Muendel CC, Patera A, Pochapsky TC, Kuti M, Wolfson AJ. Protein Eng 12 189-202 (1999)
  51. Synthetic alleles at position 121 define a functional domain of human interleukin-1 beta. Ambrosetti DC, Palla E, Mirtella A, Galeotti C, Solito E, Navarra P, Parente L, Melli M. Eur J Biochem 238 308-316 (1996)
  52. Computational and NMR analyses for the identification of bound water molecules in ribonuclease T1. Shimotakahara S, Hojo S, Furihata K, Tashiro M. Anal Sci 20 1471-1474 (2004)
  53. Congress 10th International Conference on Methods in Protein Structure Analysis. September 8-13, 1994, Snowbird, Utah. Short communications and abstracts. J Protein Chem 13 431-543 (1994)
  54. Mobile Point-of-Care Device Using Molecularly Imprinted Polymer-Based Chemosensors Targeting Interleukin-1β Biomarker. Park R, Jeon S, Lee JW, Jeong J, Kwon YW, Kim SH, Jang J, Han DW, Hong SW. Biosensors (Basel) 13 1013 (2023)
  55. Nuclear overhauser spectroscopy of chiral CHD methylene groups. Augustyniak R, Stanek J, Colaux H, Bodenhausen G, Koźmiński W, Herrmann T, Ferrage F. J Biomol NMR 64 27-37 (2016)
  56. Profile of Marius Clore. Samoray C. Proc Natl Acad Sci U S A 113 12604-12606 (2016)
  57. The value of chemical shift parameters in the description of protein solution structures. Gao Y, Veitch NC, Williams RJ. J Biomol NMR 1 457-471 (1991)


Related citations provided by authors (9)

  1. Four-Dimensional 13C(Slash)13C-Edited Nuclear Overhauser Enhancement Spectroscopy of a Protein in Solution: Application to Interleukin-1Beta. Clore GM, Kay LE, Bax A, Gronenborn AM Biochemistry 30 12- (1991)
  2. Four-Dimensional Heteronuclear Triple-Resonance NMR Spectroscopy of Interleukin-1Beta in Solution. Kay LE, Clore GM, Bax A, Gronenborn AM Science 249 411- (1990)
  3. Assignment of the Side-Chain 1H and 13C Resonances of Interleukin-1Beta Using Double-and Triple-Resonance Heteronuclear Three-Dimensional NMR Spectroscopy. Clore GM, Bax A, Driscoll PC, Wingfield PT, Gronenborn AM Biochemistry 29 8172- (1990)
  4. Analysis of the Backbone Dynamics of Interleukin-1Beta Using Two-Dimensional Inverse Detected Heteronuclear 15N-1H NMR Spectroscopy. Clore GM, Driscoll PC, Wingfield PT, Gronenborn AM Biochemistry 29 7387- (1990)
  5. Identification and Localization of Bound Internal Water in the Solution Structure of Interleukin 1Beta by Heteronuclear Three-Dimensional 1H Rotating-Frame Overhauser 15N-1H Multiple Quantum Coherence NMR Spectroscopy. Clore GM, Bax A, Wingfield PT, Gronenborn AM Biochemistry 29 5671- (1990)
  6. Low Resolution Structure of Interleukin-1Beta in Solution Derived from 1H-15N Heteronuclear Three-Dimensional Nuclear Magnetic Resonance Spectroscopy. Clore GM, Driscoll PC, Wingfield PT, Gronenborn AM J. Mol. Biol. 214 811- (1990)
  7. Determination of the Secondary Structure and Molecular Topology of Interleukin-1Beta by Use of Two-and Three-Dimensional Heteronuclear 15N-1H NMR Spectroscopy. Driscoll PC, Gronenborn AM, Wingfield PT, Clore GM Biochemistry 29 4668- (1990)
  8. Complete Resonance Assignment for the Polypeptide Backbone of Interleukin 1Beta Using Three-Dimensional Heteronuclear NMR Spectroscopy. Driscoll PC, Clore GM, Marion D, Wingfield PT, Gronenborn AM Biochemistry 29 3542- (1990)
  9. Overcoming the overlap problem in the assignment of 1H NMR spectra of larger proteins by use of three-dimensional heteronuclear 1H-15N Hartmann-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: application to interleukin 1 beta.. Marion D, Driscoll PC, Kay LE, Wingfield PT, Bax A, Gronenborn AM, Clore GM Biochemistry 28 6150-6 (1989)

Quick links